Inventor · disambiguated record
Nabil G. Seidah
Also filed as: SEIDAH NABIL · SEIDAH NABIL G
15 granted patents·7 pending applications·292 citations·filing 1981–2023
94Inventor score
Files withSEIDAH NABIL G5PASTEUR INSTITUT4ADAERATA LP2INST RECH S CLINIQUES DE MONTR2MONTREAL INST RECH CLINIQUES2
Top patents by PatentIndex Score
22 records- 0190US7300754B2Methods for detecting the presence of or predisposition to autosomal dominant hypercholesterolemiaINST NAT SANTE RECH MED·Filed 2004·Granted Nov 27, 2007·108 cites·5 claims
- 0284US8673850B2PCSK9 inhibitors and methods of use thereofSEIDAH NABIL G·Filed 2009·Granted Mar 18, 2014·13 cites·11 claims
- 0380US6025143AAntibodies directed against peptides derived from the SMR1 polypeptidePASTEUR INSTITUT·Filed 1995·Granted Feb 15, 2000·30 cites·11 claims
- 0477US9879093B2Single domain antibodies as inhibitors of PCSK9ADAERATA LP·Filed 2012·Granted Jan 30, 2018·3 cites·22 claims
- 0576US8088571B2Methods of reducing a viral infection and kits thereforeSEIDAH NABIL G·Filed 2008·Granted Jan 3, 2012·4 cites·5 claims
- 0675US4607023ANatriureticMONTREAL INST RECH CLINIQUES·Filed 1984·Granted Aug 19, 1986·40 cites·8 claims
- 0773US8187833B2Chimeric PCSK9 proteins, cells comprising same, and assays using sameSEIDAH NABIL G·Filed 2007·Granted May 29, 2012·3 cites·16 claims
- 0870US8338568B2Chimeric PCSK9 proteins, cells comprising same, and assays using sameSEIDAH NABIL G·Filed 2012·Granted Dec 25, 2012·2 cites·1 claims
- 0964US2005153374A1Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposesPASTEUR INSTITUT·Filed 2004·Application pending·0 cites
- 1064US2025129370A1Method for reducing hepatic triglyceridesADAERATA LP·Filed 2023·Application pending·0 cites
- 1163US6380171B1Pro-protein converting enzymeCLINICAL RES INST OF MONTREAL·Filed 1997·Granted Apr 30, 2002·26 cites·3 claims
- 1263US5859189APeptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposesPASTEUR INSTITUT·Filed 1993·Granted Jan 12, 1999·18 cites·9 claims
- 1362US5840529AMammalian pro-hormone convertaseCLINICAL RESEARCH INST OF MONT·Filed 1995·Granted Nov 24, 1998·21 cites·22 claims
- 1454US4632780AN-terminal fragment of human pro-opiomelanocortin and process thereforSEIDAH NABIL G·Filed 1981·Granted Dec 30, 1986·13 cites·2 claims
- 1550US2023149401A1Furin inhibitors for treating coronavirus infectionsBP ASSET V INC·Filed 2021·Application pending·0 cites
- 1647US6916607B2Peptides and polypeptides derived from the submaxillary gland of the rat corresponding polyclonal and monoclonal antibodies corresponding hybridomas and uses of these products for diagnosis for detection or therapeutic purposesPASTEUR INSTITUT·Filed 1999·Granted Jul 12, 2005·9 cites·2 claims
- 1746US2009130691A1Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitorsINST RECH S CLINIQUES DE MONTR·Filed 2006·Application pending·0 cites
- 1845US2010310451A1Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)UNIV MCGILL·Filed 2008·Application pending·0 cites
- 1944US2004180417A1Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin2)Filed 2001·Application pending·0 cites
- 2038US2016031935A1Small molecule modulators of pcsk9 and methods of use thereofADAERATA LTD PARTNERSHIP·Filed 2014·Application pending·0 cites
- 2135US5789564ADevelopment of research diagnostic and production tools for pro-hormone convertasesMONTREAL INST RECH CLINIQUES·Filed 1996·Granted Aug 4, 1998·1 cites·13 claims
- 2224US7211424B1Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificityINST RECH S CLINIQUES DE MONTR·Filed 1999·Granted May 1, 2007·1 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →